JPM CBRN Medical

Joint Enterprise Technology Tool (JETT)

Do you have an idea or technology that could help protect our warfighters from CBRN threats? Connect with the CPE CBRND through the Joint Enterprise Technology Tool (JETT).

Joint Enterprise Technology Tool

Contracting Overview

CPE CBRND's mission to provide integrated layered chemical, biological, radiological, and nuclear (CBRN) defense is made possible by our industry partners, who play a vital role in supporting the Joint Force.

Contracting Focus Area

Multiple Award Task Order Contract (MATOC)

MATOCs promote competition, save costs, encourage small business participation, minimize time to award, and streamline documentation. The CPE CBRND Contracting Office manages MATOCs. Click below for opportunities in each contract area.

Downloads

Other Transactions Agreements (OTA)

OTAs enable the Department of War (DoW) to access technologies from non-traditional partners. The CPE CBRND Contracting Office manages OTAs. Click below for opportunities in each OTA contract area.

Alternative Contracts

Stand-Alone Contracts

No "one size fits all" model exists for CBRND product development and production. Each collaboration is as unique as the product. Vehicle selection considerations range from acquisition history, requirement urgency, requirement complexity, and other factors.

Learn more about stand-alone contracts through the CPE CBRND Contracting Office and General Services Administration's SAM.gov

Joint Project Manager (JPM) CBRN Medical TechWatch

JPM CBRN Medical plays a vital role in enhancing the DoW’s strategy to prevent, diagnose, and treat the effects of CBRN threats and emerging infectious diseases.

Opportunities through the public-private partnership TechWatch help JPM CBRN Medical develop and acquire safe, effective, and innovative medical solutions and systems to combat CBRN and other emerging infectious diseases.

The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) aims to provide U.S. military forces and the nation with safe, effective, and innovative medical solutions to counter chemical, biological, radiological, and nuclear threats. The JPM CBRN Medical facilitates the advanced development and acquisition of medical countermeasures and systems to enhance the nation’s biodefense response capability.

Overview

The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical’s Vaccine Acceleration by Modular Progression (VAMP) is a nucleic acid vaccine development platform that facilitates rapid delivery of safe and effective nucleic acid based vaccines to the warfighter or the general population. VAMP relies on a modular contracting strategy to fund development of multiple mRNA vaccine candidates simultaneously, delivering mRNA vaccines against new and emerging biological threats to enhance overall preparedness.

Typical Vaccine Development Platform, one contract at a time, against one threat

VAMP Vaccine Development Platform
Modular Contracting Strategy: GO/NO GO checkpoints through initial Phase I development to decrease risk and maximize success of mRNA vaccine candidate. Multiple simultaneous mRNA vaccine contracts against different threat families; Partnership with industry that has proven mRNA or nucleic acid vaccine technology.

Learn more about VAMP in the article "COVID-19 Lessons Learned Pave the Way for Future Successful Emergency-Use Vaccines." VAMP vials and syringes

"Thanks to our partnerships and a broad scientific understanding of other coronaviruses, such as Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), the U.S. government and private industry partners were able to quickly develop a safe and effective COVID-19 vaccine. The success of the COVID-19 vaccine has shown us that investment in mRNA vaccines will enable us to develop a framework and strategic reserves to cover broader threat families in a more expeditious fashion."

Colonel Ryan Eckmeier
Joint Project Manager for the Chemical, Biological, Radiological, and Nuclear Medical Joint Project Management Office